Radiofrequency ablation associated to mucosal resection in the oesophagus: Experience in a single centre

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 4, 2012, Pages 371-377

  Caillol, F ^a   Bories, E ^a   Pesenti, C ^a   Poizat, F ^a   Monges, G ^a   Guiramand, J ^a   Esterni, B ^a   Giovannini, M ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; TREATMENT RESPONSE;

ADULT; AGED; BARRETT ESOPHAGUS; CATHETER ABLATION; ESOPHAGOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE;

EID: 84865973652     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.01.004     Document Type: Article

References (65)

1. Haggitt R.C. Barrett's esophagus: pathogenis, dysplasia, and adenocarcinoma. Hum Pathol 1994, 25:982-993.
2. Winters C., Spurling T.J., Chobanian S.J., et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal disease. Gastroenterology 1987, 92:118-124.
3. Pohl H., Welch H.G. The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-146.
4. Gilbert E.W., Luna R.A., Harrison V.L., Hunter J.G. Barret's esophagus: a review of the literature. J Gastrointest Surg 2011, 15:708-718.
5. Fan X., Snyder N. Prevalence of Barrett's esophagus in patients with or without GERD symptoms: role of race, age, and gender. Dig Dis Sci 2009, 54(3):572-577.
6. Wani S., Puli S.R., Shaheen N.J., et al. Esohageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009, 104:502-513.
7. Ell C., May A., Pech O., et al. Curative endoscopic resection of early esophageal adecarcinomas (Barrett's cancer). Gastrointest Endosc 2007, 65:3-10.
8. May A., Gossner L., Pech O., et al. Local endoscopic therapy for intra-epithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute phase and intermediate results of a neck treatment approach. Eur J Gastroenterol Hepatol 2002, 14:1085-1091.
9. Peters F.P., Kara M.A., Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005, 61:506-514.
10. Badredine R.J., Prasad G.A., Wang K.K., et al. Prevalence and predictors factors of recurrent neoplasia after ablation of ablation of Barrett's esophagus. Gastrointest Endosc 2010, 71:697-703.
11. Pech O., Behrens A., May A., et al. Long-term results and risk factors analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intra-epithelial dysplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57:1200-1206.
12. Pouw R.E., Sharma V.K., Bergman J.J., et al. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique. Its clinical results and future prospect. Endoscopy 2008, 40:1033-1040.
13. Inadomi J.M. Surveillance in Barrett's esophagus: a failed premise. Keio J Med 2009, 58:12-18.
14. Shaheen N.J., Provenzale D., Sandler R.S. Upper endoscopy as a screening and surveillance tool in eosphageal adenocarcinoma: a review of the evidence. Am J Gastroenterol 2002, 97:1319-1327.
15. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproductibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol 2001, 32:368-378.
16. Reid B.J., Haggitt R.C., Rubin E.C., et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Human Pathol 1988, 19:166-178.
17. Alikhan M., Rex D., Khan A., et al. Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice. Gastrointest Endosc 1999, 50:23-26.
18. Abrams J.A., Kapel R.C., Lindberg G.M., et al. Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol 2009, 7:736-742.
19. Van Vilsteren F.G., Alvarez Herrero L., Pouw R.E., Ten Kates F.J., Visser M., Seldenriijk C.A., et al. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high-grade intra-epithelial neoplasia and mucosal squamous cell carcinoma. Endoscopy 2011, 43(4):282-290.
20. Wang K.K., Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008, 103:788-797.
21. Playford R.J. New British Society of Gastroenteroly (BSG̊ guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006, 55:442.
22. Ganz R.A., Overholt B.F., Sharma V.K., et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a US multicenter registry. Gastrointest Endosc 2008, 35-40.
23. Schnell T.G., Sontag S.J., Chejfec G., et al. Long-term non surgical management of Barrett's esophgus with high-grade dysplasia. Gastroenterology 2001, 120:1607-1619.
24. Sharma V.K., Wang K.K., Overholt B.F., et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007, 65:185-195.
25. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-2288.
26. Reid B.J., Levine D.S., Longton G., Blount P.L., Rabinovitch P.S. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flox cytometry identify low and high-risk patients subsets. Am J Gastroenterol 2009, 95:1669-1676.
27. Rastogi A., Puli S., El-Serag H.B., Bansal A., Wani S., Sharma P. Incidence esophagus adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008, 67:394-398.
28. Buttar N.S., Wang K.K., Sebo T.J., et al. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001, 120:1630-1639.
29. Wani S., Puli S.R., Shaheen N.J., et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009, 104:502-513.
30. Sharma P., Falk G.W., Weston A.P., et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006, 119:33-338.
31. Shaheen N.J., Crosby M.A., Mozymski E.M., Sandler R.S. Is there any bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenteroly 2000, 119:333-338.
32. Anderson L.A., Murray L.J., Murphy S.J., et al. Mortality in Barrett's esophagus: results from a population based study. Gut 2003, 52:1081-1084.
33. Weston A.P., Sharma P., Marthur S., Banerjee S., Jafri A.K., Cherian R., et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 2004, 99:1657-1666.
34. Martinek J., Benes M., Brandtl P., Hucl T., Vasicek M., Voska L., et al. Low incidence of adenocarcinoma and high-grade intra-epithelial neoplasia in patients with Barrett's esophagus: a prospective cohort study. Endoscopy 2008, 40(9):711-716.
35. Dulai S., Shekelle P.G., Jensen D.M., Spiegel B.M., Chen J., Oh D., et al. Dysplasia and risk of further neoplastic progression in a regional veterans administration Barrett's cohort. Am J Gastroenterol 2005, 100:775-783.
36. Rudolph R.E., Vaughan T.L., Storer B.E., Haggitt R.C., Rabinovitch P.S., Levine D.S., et al. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000, 132:612-620.
37. Lyday W.D., Corbett F.S., Kupperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010, 42:272-278.
38. Dos Santos R.S., Bizekis C., Ebright M., et al. Radiofrequency ablation of Barrett's esophagus and low-grade dysplasia in combination with an anti-reflux procedure: a new paradigm. J Thorac Cardiovasc Surg 2010, 139:713-716.
39. Sharma V.K., Kim H.J., Das A., et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol 2009, 104:310-317.
40. Eldaif S.M., Lin E., Singh K.A., et al. Radiofrequency ablation of Barrett's esophagus: short-term results. Ann Thorac Surg 2009, 87:405-410.
41. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008, 40:359-369.
42. Sharma V.K., Kim H.J., Das A., et al. a prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008, 40:380-387.
43. Hernandez J.C., Reichers, Chung D., et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy 2008, 40:388-392.
44. Roorda A.K., Marcus S.N., Triadafilopoulos G. Early experience with radiofrequency energy ablation for Barrett's esophagus with or without dysplasia. Dis Esophagus 2007, 20:516-522.
45. Hubbard N., Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus in patients with fundoplication. Surg Endosc 2007, 21:625-628.
46. Pouw R.E., Whirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
47. Pouw R.E., Gondrie J.J., Sondermeijer C.M., et al. Eradication of Barrett's esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008, 12:1627-1636.
48. Van Vilsteren F.G., Pouw R.E., Seewald S., Herrero L.A., Sondermeijer C.M.T., Visser M., et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's esophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011, 60:765-773.
49. Gondrie J.J., Pouw R.E., Sondermeijer C.M., et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential an focal ablation using the Halo system. Endoscopy 2008, 40:370-379.
50. Herrero L.A., Van Vilsteren F.G., Pouw R.E., Ten Kate F.J., Visser M., Seldenrijk C.A., et al. Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10cm. Gastrointest Endosc 2011, 73(4):682-690.
51. Loeve C, Bories E, Monges G, Pesenti C, Caillol F, Giovannini M. JFPD, 2011.
52. Alvarez Herrero L., Pouw R.E., van Vilsteren F.G., ten Kate F.J., Visser M., Seldenrijk C.A., et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy 2011, 43:177-183.
53. Hornick J.L., Blount P.L., Sanchez C.A., et al. Biologic properties of columnar epithelium underneath re-epithelialized squamous mucosa in Barrett's esophagus. Am J Surg Pathol 2005, 29:372-380.
54. Basu K.K., Pick B., Bale R., et al. Efficacy and one year follow-up of argon plasma coagulation therapy for ablation of Barrett's esophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002, 51:776-780.
55. Ban S., Mino M., Nishioka N.S., et al. Histopathologic aspect of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 2004, 28:1466-1473.
56. Sharma P., Morales T.G., Bhattacharyya A., et al. Squamous islands in Barrett's esophagus: what lies underneath?. Am J Gastroenterol 1998, 93:332-335.
57. Fleisher D.E., Overholt B.F., Sharma V.K., Reymunde A., Kimmey M.B., Chutani R., et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010, 42:781-789.
58. Inadomi, editorial, Gastroenterol. 2011; 141: 417-19.
59. Vaccaro B.J., Gonzales S., Poneros J.M., Stevens P.D., Capiak K.M., Lightdale C.J., et al. Detection of intestinal metaplasia after successful eradication of Barrett's esophagus with radiofrequency ablation. Dig Dis Sci 2011.
60. Wani S., Sayana H., Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2010, 71:147-166.
61. Shaheen N.J., Overholt B.F., Sampliner R.E., Wolfsen H.C., Wang K.K., Fleischer D.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011.
62. Sharma P., Bhattacharyya A., Garewell H.S., et al. Durability of new squamousnepithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc 1999, 50:159-164.
63. Alison H., Banchs M.A., Bonis P.A., Guelrud M. Long-term remission of non-dysplastic Barrett's esophagus after multipolar electrocoagulation ablation: report of 139 patients with 10 years of follow-up. Gastrointest Endosc 2011, 73(4):651-658.
64. Overholt B.F., Wang K.K., Burdick J.S., et al. Five-years safety and efficacy of photodynamic therapy with photofrin in Barrett's high-grade-dysplasia. Gastrointest Endosc 2007, 66:460-468.
65. Shaheen N.J., Overholt B.F., Sampliner R.E., Wolsen H.C., Wang K.K., Fleischer D.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterol 2011, 141:460-468.